Search Results

There are 2623124 results for: content related to: Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges

  1. Overseeing Innovative Therapy without Mistaking It for Research: A Function-Based Model Based on Old Truths, New Capacities, and Lessons from Stem Cells

    The Journal of Law, Medicine & Ethics

    Volume 38, Issue 2, Summer 2010, Pages: 286–302, Patrick L. Taylor

    Article first published online : 21 JUN 2010, DOI: 10.1111/j.1748-720X.2010.00489.x

  2. What's Missing? Discussing Stem Cell Translational Research in Educational Information on Stem Cell “Tourism”

    The Journal of Law, Medicine & Ethics

    Volume 41, Issue 1, Spring 2013, Pages: 254–268, Zubin Master, Amy Zarzeczny, Christen Rachul and Timothy Caulfield

    Article first published online : 12 APR 2013, DOI: 10.1111/jlme.12017

  3. STEM CELL TOURISM AND FUTURE STEM CELL TOURISTS: POLICY AND ETHICAL IMPLICATIONS

    Developing World Bioethics

    Volume 12, Issue 1, April 2012, Pages: 35–44, EDNA F. EINSIEDEL and HANNAH ADAMSON

    Article first published online : 16 MAR 2012, DOI: 10.1111/j.1471-8847.2012.00319.x

  4. INTRODUCTION

    The Journal of Law, Medicine & Ethics

    Volume 38, Issue 2, Summer 2010, Pages: 175–190, John A. Robertson

    Article first published online : 21 JUN 2010, DOI: 10.1111/j.1748-720X.2010.00478.x

  5. STEM CELL TREATMENTS IN CHINA: RETHINKING THE PATIENT ROLE IN THE GLOBAL BIO-ECONOMY

    Bioethics

    Volume 27, Issue 4, May 2013, Pages: 194–207, HAIDAN CHEN and HERBERT GOTTWEIS

    Article first published online : 17 NOV 2011, DOI: 10.1111/j.1467-8519.2011.01929.x

  6. Questions Concerning the Clinical Translation of Cell-Based Interventions under an Innovation Pathway

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 4, Winter 2012, Pages: 945–950, Jeremy Sugarman

    Article first published online : 3 JAN 2013, DOI: 10.1111/j.1748-720X.2012.00723.x

  7. The Roles and Responsibilities of Physicians in Patients' Decisions about Unproven Stem Cell Therapies

    The Journal of Law, Medicine & Ethics

    Volume 40, Issue 1, Spring 2012, Pages: 122–134, Aaron D. Levine and Leslie E. Wolf

    Article first published online : 27 MAR 2012, DOI: 10.1111/j.1748-720X.2012.00650.x

  8. Responding to requests of families for unproven interventions in neurodevelopmental disorders: Hyperbaric oxygen “treatment” and stem cell “therapy” in cerebral palsy

    Developmental Disabilities Research Reviews

    Volume 17, Issue 1, 2011, Pages: 19–26, Emily Bell, Tessa Wallace, Isabelle Chouinard, Michael Shevell and Eric Racine

    Article first published online : 23 MAR 2012, DOI: 10.1002/ddrr.134

  9. International Nonproprietary Names and Trademarks: A Public Health Perspective

    The Journal of World Intellectual Property

    Volume 11, Issue 2, March 2008, Pages: 63–104, Kappoori M. Gopakumar and Nirmalya Syam

    Article first published online : 7 MAY 2008, DOI: 10.1111/j.1747-1796.2008.00335.x

  10. Currents in Contemporary Ethics The Implications of Expanding Access to Unapproved Drugs

    The Journal of Law, Medicine & Ethics

    Volume 35, Issue 2, Summer 2007, Pages: 316–319, Meghan K. Talbott

    Article first published online : 19 MAY 2007, DOI: 10.1111/j.1748-720X.2007.00141.x

  11. Therapeutic journeys: the hopeful travails of stem cell tourists

    Sociology of Health & Illness

    Volume 36, Issue 5, June 2014, Pages: 670–685, Alan Petersen, Kate Seear and Megan Munsie

    Article first published online : 25 NOV 2013, DOI: 10.1111/1467-9566.12092

  12. You have free access to this content
    Citation classics: Top 50 cited articles in ‘respiratory system’

    Respirology

    Volume 18, Issue 1, January 2013, Pages: 71–81, WILSON W.S. TAM, ELIZA L.Y. WONG, FAYE C.Y. WONG and DAVID S.C. HUI

    Article first published online : 26 DEC 2012, DOI: 10.1111/j.1440-1843.2012.02262.x

  13. Medical and Innovative Therapies for Biliary Malignancies

    Diseases of the Gallbladder and Bile Ducts: Diagnosis and Treatment, Second Edition

    Michael A. Morse, Bernhard Pestalozzi, Pages: 205–214, 2007

    Published Online : 25 OCT 2007, DOI: 10.1002/9780470986981.ch11

  14. Competing Institutional Logics in the Biopharmaceutical Industry: The Move away from the Small Molecules Therapies Model in the Post-Genomic Era

    Creativity and Innovation Management

    Volume 20, Issue 4, December 2011, Pages: 311–329, Alexander Styhre

    Article first published online : 15 NOV 2011, DOI: 10.1111/j.1467-8691.2011.00615.x

  15. 49.2: Invited Paper: A Transparent AMOLED with On-cell Touch Function Driven by IGZO Thin-Film Transistors

    SID Symposium Digest of Technical Papers

    Volume 42, Issue 1, June 2011, Pages: 714–717, Hsing-Hung Hsieh, Tsung-Ting Tsai, Chen-Ming Hu, Chia-Ling Chou, Shih-Feng Hsu, Yuan-Chun Wu, Ching-Sang Chuang, Lee-Hsun Chang and Yusin Lin

    Article first published online : 16 AUG 2012, DOI: 10.1889/1.3621425

  16. Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 3, Issue 7, July 2005, Pages: 511–518, Karin Berger, Birgit Ehlken, Barbara Kugland and Matthias Augustin

    Article first published online : 15 JUN 2005, DOI: 10.1111/j.1610-0387.2005.05729.x

  17. Optimal management of metastatic renal cell carcinoma: an algorithm for treatment

    BJU International

    Volume 104, Issue 1, July 2009, Pages: 10–18, Joaquim Bellmunt, Per Flodgren, Jan Roigas and Stéphane Oudard

    Article first published online : 21 APR 2009, DOI: 10.1111/j.1464-410X.2009.08563.x

  18. You have free access to this content
    Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America

    Cancer

    Volume 116, Issue 5, 1 March 2010, Pages: 1272–1280, Walter M. Stadler, Robert A. Figlin, David F. McDermott, Janice P. Dutcher, Jennifer J. Knox, Wilson H. Miller Jr, John D. Hainsworth, Charles A. Henderson, Jeffrey R. George, Julio Hajdenberg, Tamila L. Kindwall-Keller, Marc S. Ernstoff, Harry A. Drabkin, Brendan D. Curti, Luis Chu, Christopher W. Ryan, Sebastien J. Hotte, Chenghua Xia, Lisa Cupit and Ronald M. Bukowski

    Article first published online : 15 JAN 2010, DOI: 10.1002/cncr.24864

  19. Adverse events from targeted therapies in advanced renal cell carcinoma: the impact on long-term use

    BJU International

    Volume 107, Issue 11, June 2011, Pages: 1722–1732, Ziya Kirkali

    Article first published online : 20 JAN 2011, DOI: 10.1111/j.1464-410X.2010.09985.x

  20. The Patient Protection and Affordable Care Act, Public Health, and the Elusive Target of Human Rights

    The Journal of Law, Medicine & Ethics

    Volume 39, Issue 3, Fall 2011, Pages: 340–354, Lance Gable

    Article first published online : 22 AUG 2011, DOI: 10.1111/j.1748-720X.2011.00604.x